Clinical Trial Update: Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

View source ↗

Summary

Recruitment is ongoing for a biomarker evaluation study in Polycystic Ovary Syndrome (PCOS) at University Hospital Erlangen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Snippet

Sponsor: University Hospital Erlangen | Conditions: Polycystic Ovarian Syndrome (PCOS) | Status: RECRUITING